Ortiz-Prado Esteban, Iturralde Ana Lucía, Simbaña-Rivera Katherine, Gómez-Barreno Lenin, Hidalgo Iván, Rubio-Neira Mario, Espinosa Nicolás, Izquierdo-Condoy Juan, Arteaga-Espinosa María Emilia, Lister Alex, López-Cortés Andrés, Cabrera-Andrade Alejandro
One Health Research Group, Faculty of Medicine, Universidad de Las Americas, Quito, Ecuador.
Pediatrics Department, Hospital Metropolitano, Quito, Ecuador.
Case Rep Med. 2021 May 3;2021:6662054. doi: 10.1155/2021/6662054. eCollection 2021.
The 15q11.1-13.1 duplication, also known as Dup15q syndrome, is a rare congenital disease affecting 1 in 30,000 to 1 in 60,000 children worldwide. This condition is characterized by the presence of at least one extra copy of genetical material within the Prader-Willi/Angelman Critical Region (PWACR) of the referred 15q11.2-q13.1 chromosome. . Our study presents the clinical and genetical features of the first patient with a 15q11.2 interstitial duplication on the maternal allele (inv Dup15q) that mimics a milder Prader-Willi syndrome probably due to an atypical disruption of the 14 gene. Methylation-specific MLPA analysis has confirmed the presence of a very unlikely duplication that lies between breakpoint 1 (BP1) and the middle of BP2 and BP3 (BP3). This atypical alteration might be linked to the milder patient's clinical phenotype.
This is the first Dup15q patient reported in Ecuador and of the very few in South America. This aberration has never been described in a patient with Dup15q, and the unusual clinical presentation is probably due to the atypical distal breakpoint occurring within the gene which lies between BP2 and BP3 and does not therefore contain the whole PWACR. If the duplication disrupted the gene, then it is possible that it is the cause of, or contributing to, the patient's clinical phenotype.
15q11.1 - 13.1重复,也称为Dup15q综合征,是一种罕见的先天性疾病,全球每30000至60000名儿童中就有1人受其影响。这种疾病的特征是在15号染色体11.2 - q13.1的普拉德 - 威利/安吉尔曼关键区域(PWACR)内至少存在一份额外的遗传物质拷贝。我们的研究呈现了首例母源等位基因15q11.2间质性重复(inv Dup15q)患者的临床和遗传特征,该患者可能由于14个基因的非典型破坏而表现出较轻的普拉德 - 威利综合征。甲基化特异性多重连接探针扩增(MLPA)分析证实了在断点1(BP1)与BP2和BP3中间(BP3)之间存在一个极罕见的重复。这种非典型改变可能与该患者较轻的临床表型有关。
这是厄瓜多尔报道的首例Dup15q患者,也是南美洲极少数此类患者之一。这种畸变在Dup15q患者中从未被描述过,其不寻常的临床表现可能是由于位于BP2和BP3之间的基因内出现非典型远端断点,因此不包含整个PWACR。如果该重复破坏了该基因,那么它有可能是患者临床表型的病因或促成因素。